Delivery Order HHSA290201200003I-HHSA29032002T
Award Date 9/30/12
Potential Completion Date 9/29/14
Potential Value $3.2M
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost No Fee
Place of Performance
Palo Alto, CA 94305, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Health Agency awarded a $12.39 million firm fixed-price purchase order to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. on February 15, 2023, to conduct a casualty care assessment of the Russo-Ukraine War. The contract, which has no set-aside designation and extends through September 29, 2025, will be performed in Frederick, Maryland. This work directly supports Section 736 of the Fiscal Year 2021 National Defense Authorization Act, which directed the...
- Rivanna Medical, Inc. has been awarded a $91.5 million cost-plus-fixed-fee definitive contract by the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the Department of Health and Human Services to develop, refine, and manufacture the Accuro XV, a handheld ultrasound device designed for rapid, radiation-free fracture triage in mass casualty blast trauma incidents. The contract, which is not set-aside and has an ultimate completion date of September 29, 2029,...
- The National Heart Lung and Blood Institute (NHLBI) awarded a definitive cost-plus-no-fee contract to Fred Hutchinson Cancer Research Center for the Women's Health Initiative (WHI) Clinical Coordinating Center, effective April 1, 2016, with a ceiling value of approximately $60.3 million and an ultimate completion date of January 31, 2021. This non-set-aside contract is performed in Seattle, Washington, and represents the NHLBI's continued investment in the WHI, a landmark longitudinal study...
- The National Institute on Drug Abuse awarded a $17.67M definitive contract to Greater Los Angeles Veterans Research and Education Foundation (GLAVREF) to establish and operate the NIH Neurobiobank Brain and Tissue Repository (NBB), a collection site designed to acquire, process, store, curate, preserve, and distribute central nervous system and related tissue specimens. Under the solicitation 75N95024R00124, which represents a multi-agency initiative including the National Institute of Mental...
- The National Institute on Drug Abuse awarded a definitive contract valued at $18.5 million to the Icahn School of Medicine at Mount Sinai (ISMMS) to establish and operate the NIH NeuroBank Brain and Tissue Repository (NBB), a collection site dedicated to acquiring, processing, storing, curating, preserving, and distributing central nervous system and related tissues for research purposes. This cost-plus-no-fee contract, which commenced on November 1, 2025, and extends through October 31, 2030,...
- The University of Oklahoma Health Sciences Center (OUHSC), through its Coordinating Center division, was awarded a delivery order valued at $14.63 million by the National Heart, Lung, and Blood Institute (NHLBI) for Task Order 001 of the Strong Heart Study (SHS) Coordinating Center. This cost-no-fee contract was awarded on February 15, 2019, with an ultimate completion date of February 14, 2027, and will span 66 months of study coordination activities across the performance period. The award...
- The Defense Health Agency awarded a $23,697.13 firm fixed-price call order to Harvard Bioscience Inc. (operating as Data Sciences International) on December 5, 2024, for medical research implants, with performance scheduled to conclude by September 30, 2025. This contract call is issued under Harvard Bioscience's existing $4.8 million single-award Blanket Purchase Agreement with the Defense Health Agency, which was established on May 4, 2022, and remains active through May 3, 2027. The BPA...
- The International AIDS Vaccine Initiative Inc. (IAVI) was awarded a $166.9 million firm fixed-price definitive contract by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to advance the development of monovalent vaccines for the prevention of Marburg virus (MARV) and Sudan ebolavirus (SUDV) disease. The vaccines are based on recombinant expression of filovirus glycoproteins and represent critical medical countermeasures against emerging infectious disease threats....
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a definitive cost-no-fee contract valued at $91.8 million to the University of Georgia Research Foundation (UGA CEIRR) on April 1, 2021, with an ultimate completion date of March 24, 2028. This award establishes one of up to seven Centers of Excellence for Influenza Research and Response (CEIRR) under NIAID's multi-disciplinary collaborative network initiative. The contract supports integrated basic and clinical...
- Emory University was awarded contract 75N93021C00017 on April 1, 2021 by the National Institute of Allergy and Infectious Diseases (NIAID) to establish and operate a Center of Excellence for Influenza Research and Response (CEIRR). The five-year contract, valued at $79.3 million through its September 2028 completion date, operates on a cost reimbursable basis with no fee. The award supports NIAID's initiative to create a multi-disciplinary collaborative network focused on advancing understanding...